Search results
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 9 hours agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 10 hours agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 8 hours agoFood and Drug Administration (FDA) has approved its respiratory syncytial virus (RSV) vaccine for...
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 13 hours agoLike Moderna’s vaccine for COVID-19, which was... vaccine relies on the Cambridge biotech’s...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 7 hours ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 12 hours agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 13 hours agoRSV, the shorthand for respiratory syncytial virus, causes coldlike symptoms in most people. But it...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 13 hours agoThe decision is a win for Moderna, which desperately needs another revenue source amid plunging...
FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company
The National Law Review· 6 hours agoOn May 21, 2024, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 13 hours agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...